Abeona Therapeutics Inc (NASDAQ: ABEO) stock suffered a major decline of -19.0% on 3/18/24. The shares closed at $6.99. Moreover, this decline was accompanied by exceptionally high trading volume at 385% of normal. The stock has declined -12.3% during the last week but has been exceptionally strong relative to the market over the last nine months.
Current PriceTarget Research Rating
Reflecting future returns on capital that are forecasted to be in line with the cost of capital, ABEO is expected to continue to be Value Creation neutral.
Abeona Therapeutics has a current Value Trend Rating of C (Low Neutral). The Value Trend Rating reflects very contradictory signals from PTR’s two proprietary measures of a stock’s attractiveness. Abeona Therapeutics has a very low Appreciation Score of 1 but a very high Power Rating of 95, resulting in the Low Neutral Value Trend Rating.
Rating Review
In light of this highly negative price change we are reviewing our current Overall Rating of C. This review will be completed in the next several days.
Be the first to comment